X-ray of a healthy thigh bone and one that was treated and healed with the new method
Researchers at Lund University in Sweden, in collaboration with colleagues in Dresden, Germany, have developed a way of combining a bone substitute and drugs to regenerate bone and heal severe fractures in the thigh or shin bone.
The study, published in the research journal Science Advances, was conducted on rats, but the researchers think that the method in various combinations will soon be commonplace in clinical settings.
“The drugs and materials we used in the study for the regeneration of bone are already approved. We simply packaged them in a new combination. Therefore, there are no real obstacles to already using the method in clinical studies for certain major bone defects that are difficult to resolve in patients. But we want to introduce the technique in a controlled form via clinical studies and have recently been granted ethical approval”, says Deepak Raina, orthopaedics researcher and the lead author of the study.
Bones in the human body have a fantastic ability to repair injury, but some defects are so large or complicated that the healing process is delayed or absent. This may be due to the bone having been subjected to a major trauma in connection with a traffic accident for example, or a tumour or infection causing a major bone defect. These cases are currently treated through bone transplantation, usually with bone taken from the patient’s own pelvis.
“In cases involving severe open fractures in the lower leg, over 5 per cent of all fractures fail to heal. With our method, we will be able to avoid taking bone from the pelvis, which is a major gain for the patient.”
There is a need for new solutions and several research teams, both in Europe and in the USA, are working on improving the bone healing process. So far, the injectable cocktail successfully mixed by the Swedish and German researchers consists of three different components: an artificial ceramic material developed in Lund, a bioactive bone protein (rhBMP-2) and a drug, bisphosphonate, that combats bone resorption.
“The bone protein we use has had negative effects in previous studies due to a secondary premature bone resorption, among other things. We have successfully mitigated this effect with the bisphosphonate and, by packaging the drug in a slowly resorbing bone substitute, we can control the speed of release. In the current study with the combination, we achieved a six-fold reduction in the amount of protein compared to previous efforts, while still inducing bone formation. The result was that even fractures with an extensive bone defect could heal without complications. We believe this finding will be of great clinical use in the future”, says Deepak Raina.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Entera Bio to Present Phase 2 EB613 Oral PTH Osteoporosis Treatment 3-Month Findings at the ...on August 2, 2021 at 5:32 am
The Study’s Primary Endpoint was Met; P1NP, a Biochemical Marker of Bone Formation, was Significantly Increased at Month 3 in EB613 2.5 mg Treatment Group Versus Placebo ‒ ‒ Full 3-Month Biochemical ...
- Orthobiologics Market | is Projected to reach USD 8,261.6 Million by 2026, Exhibiting a CAGR of 4.5% During the Forecast Period 2021-2026on August 1, 2021 at 11:31 pm
The global Orthobiologics Market is anticipated to witness considerable growth with the rising number of cases regarding sports injuries and road accidents. Fortune Business Insights published the ...
- Sandcastle Worm Makes Home of Beads (IMAGE)on August 1, 2021 at 9:07 am
A synthetic version of this seaworthy glue has been developed at the University of Utah for possible use in repairing small fragments of bone in people with fractured knee, wrist and other joint bones ...
- Punjab professors get patent for developing bone grafton July 28, 2021 at 8:08 am
Punjab University professor Seema Kapoor and Punjab Engineering College professor and head Uma Batra have received a patent for a bone graft material ...
- Global Artificial Bone Market to Surpass US$ 2,017.6 Million by 2028, Says Coherent Market Insights (CMI)on July 28, 2021 at 7:15 am
According to Coherent Market Insights, the global artificial bone market is estimated to be valued at US$ 1,375.1 million in 2021 and is expected to exhibit a CAGR of 5.6% during the forecast period ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Stem Cell Dormancy Could Hold the Key to Future Cancer Therapieson August 4, 2021 at 5:00 am
Every year, tens of thousands of people around the world receive bone marrow transplants to help fight leukemia ... Stem cell transplants are used to regenerate a patient’s heathy blood supply, but ...
- Bioengineered Scaffold Guides Endogenous Bone Regenerationon August 4, 2021 at 3:14 am
Researchers have engineered a regenerative implant that could help repair bone-deep damage following physical trauma, surgery or osteoporosis.
- Robert Guldberg, Georgia Institute of Technology Research News (1 of 2) (IMAGE)on August 3, 2021 at 5:05 pm
Georgia Tech mechanical engineering professor Robert Guldberg displays a histological image showing cellular bone and cartilage regeneration integrated with a scaffold that was implanted into a large ...
- Researchers discover key stem cell dormancy mechanism which could help unlock future cancer treatmentson August 3, 2021 at 12:08 pm
Researchers have made new findings which provide a broader understanding of how dormant hematopoietic stem cells are activated and could pave the way towards therapeutic treatments for a number of ...
- Implant shows extreme promise for regenerating boneon August 3, 2021 at 8:44 am
Its powers may not rival Wolverine's, but a regenerative implant engineered by researchers at the University of Nebraska Medical Center and University of Nebraska–Lincoln could help repair bone-deep ...